Peidong Liu
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Transcription Factor Signatures May Predict the Prognosis and Status of the Immune Microenvironment of Primary Lower-Grade Gliomas.
Journal: International journal of general medicine
Published: August 21, 2021
Calcium-Related Gene Signatures May Predict Prognosis and Level of Immunosuppression in Gliomas.
Journal: Frontiers in oncology
Published: May 11, 2021
ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma.
Journal: Theranostics
Published: October 25, 2019
CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma.
Journal: Cancer gene therapy
Published: June 25, 2019
Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 06, 2019
Molecular and clinical characterization of Galectin-9 in glioma through 1,027 samples.
Journal: Journal of cellular physiology
Published: February 23, 2019
Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses.
Journal: Disease markers
Published: February 21, 2019
NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.
Journal: Journal of cellular physiology
Published: January 29, 2018
Bioinformatic analyses reveal the key pathways and genes in the CXCR4 mediated mesenchymal subtype of glioblastoma.
Journal: Molecular medicine reports
Published: November 24, 2017
IL-23 and IL-27 Levels in Serum are Associated with the Process and the Recovery of Guillain-Barré Syndrome.
Journal: Scientific reports
Published: November 07, 2017
Last Updated: 09/26/2026